The Traderszone Network

Published in TZ Latest News 9 December, 2014 by The TZ Newswire Staff

Merck says still plans to buy Cubist, despite patent setback

Merck & Co Inc said on Tuesday it will proceed with its planned $8.4 billion purchase of Cubist Pharmaceuticals Inc and still expects the deal to boost its long-term earnings, despite a court ruling that …